RNA Interference and Cancer Therapy [E-Book] : Methods and Protocols / edited by Lekha Dinesh Kumar.
This comprehensive volume collects a repertoire of techniques for the adoption and exploitation of RNA interference (RNAi) as a fertile strategy to develop the bio-drugs of future in the vital field of cancer research. Exploring the immense 'bench to bedside' potential of RNAi as a therape...
Saved in:
Full text |
|
Personal Name(s): | Dinesh Kumar, Lekha, editor |
Edition: |
1st edition 2019 |
Imprint: |
New York, NY :
Humana Press,
2019
|
Physical Description: |
XIII, 416 pages 112 illustrations, 84 illustrations in color (online resource) |
Note: |
englisch |
ISBN: |
9781493992201 |
DOI: |
10.1007/978-1-4939-9220-1 |
Series Title: |
/* Depending on the record driver, $field may either be an array with
"name" and "number" keys or a flat string containing only the series
name. We should account for both cases to maximize compatibility. */?>
Methods in Molecular Biology ;
1974 |
Subject (ZB): | |
Subject (LOC): | |
Classification: |
- siRNA Library Screening to Identify Complementary Therapeutic Pairs in Triple Negative Breast Cancer Cells
- In Vitro Evaluation of Candidate Gene Targets for Cancer Therapy
- siRNA-Based Drug Targeting Human Bcl-xL against Cancers
- Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly-Active siRNAs
- VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier
- Design Strategy to Access siRNA-Encapsulating DNA "Nanosuitcases" that Can Conditionally Release their Cargo
- Combinatorial siRNA Polyplexes for Receptor Targeting
- Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy
- Minicell-Based Targeted Delivery of shRNA to Cancer Cells: An Experimental Protocol
- Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo
- Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles
- Targeting Cancer with Peptide RNAi Nanoplexes
- Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles
- Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery
- Synthesis of Gold Nanoparticles for Gene Silencing
- Design of Eco-Friendly Gold Nanoparticles for Cancer Treatment
- 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery
- Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer
- Bio-Drug Suppresses Breast and Colorectal Cancer in Murine Models
- Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment
- Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells
- Vaginal Suppositories with siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical Cancer: Preparation and In Vitro Evaluation
- The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models
- Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer
- Synthesis, Physico-Chemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma
- Folate-Decorated Polyamidoamine Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy.